ABG Sundal Collier

Bronwyn Brophy O'Connor, CEO Vitrolife AB, has acquired 19,350 shares worth 2,495,957 SEK. The total holdings of shares amount to 19,350.
The...

Maria Forss, has resigned from her position in the Vitrolife Group as she will assume the role of CEO BICO Group AB. We are currently working on a...

According to plan and as previously announced, Henrik Blomquist will step down as Chairman of the Board of Vitrolife AB (publ) and the Board of Di...

Second quarter
Sales of SEK 905 (829) million, an increase of 9%, or 10% excluding discontinued business. In local currencies the growth ...

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2023. The presentation will be held in E...

At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
Resolution in accordance w...

First quarter
Sales of SEK 854 (752) million, an increase of 14%, and 9% in local currencies excluding discontinued business.
In loc...

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1, 2023. The presentation will be held in E...

Vitrolife Group has today published its Annual and Sustainability Report for 2022.
The Annual and Sustainability Report is now available digi...

The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on Thursday 27 April 2023 at 4.00 ...

Fourth quarter
Sales of SEK 855 (514) million, corresponding to an increase of 66% in SEK, whereof organic growth 11%, acquired growth 37...

Bronwyn Brophy has an impressive track record as a leader of global Life science and Medtech businesses. The Board of directors find Bronwyn Broph...

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the Year-end report, 2022. The presentation will be held in Eng...

Press the button and be introduced to a new random company!